COVID-19 Vaccine update: learn about the clinical efficacy and safety data for a new recombinant protein subunit COVID-19 vaccine approved and available in >35 countries. The video can be viewed at your convenience.
NUVAXOVIDᵀᴹ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) For Individuals 12 Years and Older – Switzerland
>